Biliary Radiofrequency Ablation
Biliary Radiofrequency Ablation - Related Videos
08:14
Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration
0 Views •
Cited by 18 •
2015
To help assess the molecular mechanisms underlying zebrafish biliary-driven liver regeneration, we established a liver injury model in which the nitroreductase-expressing hepatocytes are genetically ablated upon metronidazole treatment. In this protocol, we describe how to adeptly manipulate, monitor and analyze hepatocyte ablation and biliary-driven liver regeneration.
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
0 Views •
Cited by 19 •
2011
A thermal tumor ablation procedure is described. The entire procedure is detailed, including pretreatment planning and imaging studies, anesthesia, adjuvant techniques to facilitate a percutaneous approach, imaging guidance of the ablation device to the tumor, thermal treatment, post-treatment care and follow-up.
04:32
Biliary System Resin Casting: A Technique for Analyzing 3D Architecture of Biliary System in Murine Model Using Radiopaque Resin Injection
0 Views •
2025
This video describes the procedure for biliary system resin casting, for understanding 3D biliary architecture. This technique provides insights into the internal diameter and network connectivity of the biliary system, which could be used for liver regeneration analysis.
04:58
Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation
0 Views •
Cited by 4 •
2022
This study utilized advanced informatics techniques to compare procedure duration in patients undergoing radiofrequency atrial ablation treated with active esophageal cooling to those treated with traditional luminal esophageal temperature monitoring. Contextual inquiry, workflow analysis, and data mapping were utilized. The findings demonstrated reduced procedure time and variability with active cooling.
07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
0 Views •
Cited by 1 •
2022
Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) is an alternative method of biliary decompression in malignant biliary obstruction. Here we describe the technique of EUS guided-Hepaticogastrostomy (EUS-HGS) in a case of unresectable malignant hilar biliary obstruction.
FAQs
An intraductal radiofrequency catheter delivers alternating electrical current into the bile duct. This produces localized heating, which causes coagulative necrosis, meaning irreversible thermal tissue injury. Because the energy is controlled and concentrated at the treatment site, the approach is intended to limit injury to nearby structures while treating diseased tissue within the duct.
The catheter and stent serve different purposes. The intraductal catheter applies thermal treatment to diseased tissue, whereas the biliary stent is placed afterward to support drainage through the treated duct. Separating ablation from drainage allows the intervention to address both local tissue destruction and the mechanical problem of impaired bile flow.
Clinical use centers on malignant biliary obstruction, especially when the cancer is unresectable and treatment is palliative. The technique has also been used for selected strictures, but the overview does not imply that every stricture is suitable. This distinction matters because candidacy depends on the disease context and the intended goal of treatment.
A typical treatment sequence begins with endoscopic access to the bile ducts, followed by positioning of the intraductal catheter at the diseased area. Controlled radiofrequency energy is then delivered, and a biliary stent can be placed to maintain drainage. This sequence links local ablation with restoration of bile flow as part of treatment.
The approach is most relevant when biliary cancer cannot be surgically removed and the treatment objective is palliation, including relief of obstruction-related symptoms and support of bile drainage. It may also be considered for selected biliary strictures. Thus, its role is therapeutic and supportive rather than presented as a curative cancer treatment.
Potential outcomes include tissue ablation, symptom relief, improved biliary drainage, and potentially longer stent patency. Survival benefit remains an area of ongoing research, so these procedural outcomes should not be treated as proof of improved survival. This distinction helps interpret clinical studies evaluating the technique in malignant biliary obstruction.